WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2014177656) AN ANTICOAGULATION FLUID COMPRISING CITRATE AND PHOSPHATE
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2014/177656    International Application No.:    PCT/EP2014/058912
Publication Date: 06.11.2014 International Filing Date: 30.04.2014
IPC:
A61K 31/194 (2006.01), A61K 31/7004 (2006.01), A61K 33/10 (2006.01), A61K 33/14 (2006.01), A61K 33/42 (2006.01), A61P 7/08 (2006.01), A61K 9/08 (2006.01)
Applicants: GAMBRO LUNDIA AB [SE/SE]; P.O. Box 10101 S-220 10 Lund (SE)
Inventors: STERNBY, Jan; (SE).
WIESLANDER, Anders; (SE)
Agent: JÖNSSON, Anneli; P.O. Box 10101 S-220 10 Lund (SE)
Priority Data:
1350533-4 30.04.2013 SE
1350534-2 30.04.2013 SE
Title (EN) AN ANTICOAGULATION FLUID COMPRISING CITRATE AND PHOSPHATE
(FR) FLUIDE ANTICOAGULATION COMPRENANT DU CITRATE ET DU PHOSPHATE
Abstract: front page image
(EN)The present invention concerns an anticoagulation fluid comprising 10- 40 m M citrate and 0.1-4 m M phosphate. The anticoagulation fluid is to be used for regional citrate anticoagulation in an extracorporeal blood circuit. The anticoagulation fluid may be combined with at least one treatment fluid in the dialysis treatment, and it may be included in a system for regional citrate anticoagulation in an extracorporeal blood circuit.
(FR)La présente invention concerne un fluide anticoagulation comprenant 10 à 40 mM de citrate et 0,1 à 4 mM de phosphate. Le fluide anticoagulation est destiné à être utilisé pour l'anticoagulation régionale au citrate dans un circuit sanguin extracorporel. Le fluide anticoagulation peut être combiné à au moins un fluide de traitement dans le traitement par dialyse, et il peut être inclus dans un système destiné à l'anticoagulation régionale au citrate dans un circuit sanguin extracorporel.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JP, KE, KG, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, RU, TJ, TM)
European Patent Office (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)